Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Chronology: Data-driven Sports Image Indexing Research ‎[27,789 bytes]
  2. (hist) ‎Reading Lists ‎[27,416 bytes]
  3. (hist) ‎Downloading and Initial Prepping of Spreadsheets for Category 1 Games 2014 to Present ‎[19,254 bytes]
  4. (hist) ‎Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5) ‎[18,500 bytes]
  5. (hist) ‎Section 3: COVID-19: Neuro-invasive potential of SARS-nCoV-2 as cause of delirium (from DOI: 10.1186/s13054-020-02882-x) ‎[12,777 bytes]
  6. (hist) ‎SLIS-DE Retention Study 2018 ‎[11,789 bytes]
  7. (hist) ‎Main Page ‎[10,508 bytes]
  8. (hist) ‎Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[10,183 bytes]
  9. (hist) ‎Reading List - Paper I ‎[9,878 bytes]
  10. (hist) ‎Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[9,771 bytes]
  11. (hist) ‎Section 3.5. Methods of Sequencing Data Analysis (from DOI: 10.3390/v12020211) ‎[9,735 bytes]
  12. (hist) ‎Section 2: COVID-19: Potential factors contributing to ICU delirium (from DOI: 10.1186/s13054-020-02882-x) ‎[8,744 bytes]
  13. (hist) ‎Section 3.2. Problems of Metagenomic Approach (from DOI: 10.3390/v12020211) ‎[8,737 bytes]
  14. (hist) ‎Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[8,632 bytes]
  15. (hist) ‎Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) ‎[8,550 bytes]
  16. (hist) ‎Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[8,343 bytes]
  17. (hist) ‎2018-19 Academic Year Research Report ‎[8,259 bytes]
  18. (hist) ‎Crowdsourcing Bib - RGC Grant ‎[7,991 bytes]
  19. (hist) ‎Computational Practices Adapted to Archival Science ‎[7,936 bytes]
  20. (hist) ‎Section 2.3: Congenital and perinatal infections with SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372) ‎[7,165 bytes]
  21. (hist) ‎Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5) ‎[7,136 bytes]
  22. (hist) ‎Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[6,873 bytes]
  23. (hist) ‎Data-driven Semantic Indexing of Time-based Broadcast Media Series ‎[6,840 bytes]
  24. (hist) ‎Section 4: Host response to SARS-CoV-2 (from DOI: 10.1016/j.clim.2020.108427) ‎[6,712 bytes]
  25. (hist) ‎Section 1: Introduction (from DOI: 10.1186/s13054-020-02882-x) ‎[6,526 bytes]
  26. (hist) ‎Section 3.3.2. Hybridization-Based Enrichment (from DOI: 10.3390/v12020211) ‎[6,517 bytes]
  27. (hist) ‎Section 3: The Role of Host Immune Response (from DOI: 10.1007/s11886-020-01292-3) ‎[6,445 bytes]
  28. (hist) ‎Slidedecks about Wikidata ‎[6,391 bytes]
  29. (hist) ‎Section 4. Long Read Sequencing (from DOI: 10.3390/v12020211) ‎[6,222 bytes]
  30. (hist) ‎Section 2: Epidemiological data of COVID-19 (from DOI: 10.1016/j.clim.2020.108427) ‎[6,204 bytes]
  31. (hist) ‎2019-20 Academic Year Research Progress Report ‎[6,136 bytes]
  32. (hist) ‎Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5) ‎[6,077 bytes]
  33. (hist) ‎RGC Grant Report - 2019-2021 ‎[6,045 bytes]
  34. (hist) ‎Section 3.3.3. Target Amplification (from DOI: 10.3390/v12020211) ‎[5,874 bytes]
  35. (hist) ‎Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653) ‎[5,688 bytes]
  36. (hist) ‎Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) ‎[5,530 bytes]
  37. (hist) ‎Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[5,419 bytes]
  38. (hist) ‎Publications and Presentations ‎[5,324 bytes]
  39. (hist) ‎Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148) ‎[5,147 bytes]
  40. (hist) ‎Section 1: Introduction (from DOI: 10.3201/eid2605.200146) ‎[5,142 bytes]
  41. (hist) ‎Section 4: Discussion (from DOI:10.14218/ERHM.2020.00023) ‎[5,126 bytes]
  42. (hist) ‎Section 2. Traditional Methods of Diagnosing Infections (from DOI: 10.3390/v12020211) ‎[5,053 bytes]
  43. (hist) ‎Plays with Example UA Images May 2019 ‎[4,654 bytes]
  44. (hist) ‎Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) ‎[4,560 bytes]
  45. (hist) ‎Academic Articles ‎[4,521 bytes]
  46. (hist) ‎Section 3.1. Metagenomic Approach (from DOI: 10.3390/v12020211) ‎[4,503 bytes]
  47. (hist) ‎Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[4,500 bytes]
  48. (hist) ‎Data Preparation Procedures ‎[4,439 bytes]
  49. (hist) ‎Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[4,436 bytes]
  50. (hist) ‎Section 5: Potential explanation for the difference between children and adults in COVID-19 (from DOI: 10.1016/j.clim.2020.108427) ‎[4,234 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:LongPages"